Cite
Blasi M, Negri D, Saunders KO, et al. Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs. NPJ Vaccines. 2020;5(1):107doi: 10.1038/s41541-020-00252-w.
Blasi, M., Negri, D., Saunders, K. O., Baker, E. J., Stadtler, H., LaBranche, C., Mildenberg, B., Morton, G., Ciarla, A., Shen, X., Wang, Y., Rountree, W., Balakumaran, B., Santra, S., Haynes, B. F., Moody, A. M., Cara, A., & Klotman, M. E. (2020). Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs. NPJ vaccines, 5(1), 107. https://doi.org/10.1038/s41541-020-00252-w
Blasi, Maria, et al. "Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs." NPJ vaccines vol. 5,1 (2020): 107. doi: https://doi.org/10.1038/s41541-020-00252-w
Blasi M, Negri D, Saunders KO, Baker EJ, Stadtler H, LaBranche C, Mildenberg B, Morton G, Ciarla A, Shen X, Wang Y, Rountree W, Balakumaran B, Santra S, Haynes BF, Moody AM, Cara A, Klotman ME. Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs. NPJ Vaccines. 2020 Nov 18;5(1):107. doi: 10.1038/s41541-020-00252-w. PMID: 33298954; PMCID: PMC7674457.
Copy
Download .nbib